Literature DB >> 15728189

Crystal structure of CC3 (TIP30): implications for its role as a tumor suppressor.

Kamel El Omari1, Louise E Bird, Charles E Nichols, Jingshan Ren, David K Stammers.   

Abstract

CC3 (TIP30) is a protein with pro-apoptotic and anti-metastatic properties. The tumor suppressor effect of CC3 has been suggested to result from inhibition of nuclear transport by binding to importin betas or by regulating transcription through interaction in a complex with co-activator independent of AF-2 function (CIA) and the c-myc gene. Previous biochemical studies indicated that CC3 has protein kinase activity, and a structural similarity to cAMP-dependent protein kinase catalytic subunit was proposed. By contrast, bioinformatics studies suggested a relationship of CC3 to the short chain dehydrogenase reductase family. To clarify details of the CC3 structural family and ligand binding properties, we have determined the crystal structure of CC3 at 1.7-A resolution. CC3 has a short chain dehydrogenase reductase fold and binding specificity for NADPH, yet it is unlikely to be normally enzymatically active because it is monomeric. These structural results, in conjunction with data from earlier mutagenesis work on the nucleotide binding motif, suggest that NADPH binding is important for the biological activity of CC3, including interaction with importins and with the CIA/c-myc system. CC3 provides an example of the adaptation of a metabolic enzyme fold to include a regulatory role, as also seen in the case of the NADH-binding co-repressor CtBP.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15728189     DOI: 10.1074/jbc.M501113200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Crystallization and preliminary X-ray crystallographic analysis of the short-chain dehydrogenase/reductase-type DDB_G0291732 protein from Dictyostelium discoideum.

Authors:  Min Kyu Kim; Hyung Soon Yim; Sa Ouk Kang
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-12-23

2.  HSCARG regulates NF-kappaB activation by promoting the ubiquitination of RelA or COMMD1.

Authors:  Min Lian; Xiaofeng Zheng
Journal:  J Biol Chem       Date:  2009-05-11       Impact factor: 5.157

3.  Abnormal expression of TIP30 and arrested nucleocytoplasmic transport within oligodendrocyte precursor cells in multiple sclerosis.

Authors:  Jin Nakahara; Kohsuke Kanekura; Mikiro Nawa; Sadakazu Aiso; Norihiro Suzuki
Journal:  J Clin Invest       Date:  2008-12-22       Impact factor: 14.808

4.  The atypical short-chain dehydrogenases HCF173 and HCF244 are jointly involved in translational initiation of the psbA mRNA of Arabidopsis.

Authors:  Sabine Link; Kerstin Engelmann; Karin Meierhoff; Peter Westhoff
Journal:  Plant Physiol       Date:  2012-10-01       Impact factor: 8.340

5.  CC3/TIP30 regulates metabolic adaptation of tumor cells to glucose limitation.

Authors:  Vivian Chen; Emma Shtivelman
Journal:  Cell Cycle       Date:  2010-12-15       Impact factor: 4.534

6.  CC3/TIP30 affects DNA damage repair.

Authors:  Sylvia Fong; Frank King; Emma Shtivelman
Journal:  BMC Cell Biol       Date:  2010-04-07       Impact factor: 4.241

7.  Revisiting Notch in remyelination of multiple sclerosis lesions.

Authors:  Celia F Brosnan; Gareth R John
Journal:  J Clin Invest       Date:  2009-01       Impact factor: 14.808

8.  TIP30 directly binds p53 tumor suppressor protein in vitro.

Authors:  Si-Hyung Lee; Sung-Kyu Ju; Tae-Young Lee; Sung-Ho Huh; Kyou-Hoon Han
Journal:  Mol Cells       Date:  2012-11-15       Impact factor: 5.034

Review 9.  Intracellular Protein Shuttling: A Mechanism Relevant for Myelin Repair in Multiple Sclerosis?

Authors:  Peter Göttle; Patrick Küry
Journal:  Int J Mol Sci       Date:  2015-07-03       Impact factor: 5.923

Review 10.  Medium- and short-chain dehydrogenase/reductase gene and protein families : the SDR superfamily: functional and structural diversity within a family of metabolic and regulatory enzymes.

Authors:  K L Kavanagh; H Jörnvall; B Persson; U Oppermann
Journal:  Cell Mol Life Sci       Date:  2008-12       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.